Whole Genome Sequencing in Type 2 Diabetes Genetic Study
Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has sequenced the genomes of 600 individuals from 20 Mexican-American families from San Antonio in what is thought to be the largest whole genome sequencing family study conducted to date
>> read moreComplete Genomics Builds Asia-Pacific Presence, Signs Distributor Agreements in Australia, China, Japan and Korea
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, today announced that it has signed four new distributor agreements with well-established Asia-Pacific life sciences companies
>> read moreComplete Genomics Reports First Quarter 2012 Results
Complete Genomics, Inc. (Nasdaq: GNOM) today announced financial results for its quarter ended March 31, 2012.
>> read more
Complete Genomics Schedules First Quarter 2012 Earnings Release and Announces Conference Call
Complete Genomics, Inc. (Nasdaq: GNOM) will release its first quarter 2012 financial results at approximately 1:00 p.m. PDT on May 7, 2012.
>> read moreComplete Genomics Now Accepts DNA Obtained From Saliva for Whole Human Genome Sequencing
Complete Genomics Inc. (NASDAQ: GNOM) has begun accepting DNA samples derived from human saliva.
>> read moreComplete Genomics Reports Fourth Quarter and Fiscal Year 2011 Results
Complete Genomics, Inc. (Nasdaq: GNOM), the whole human genome sequencing company, today announced financial results for the fourth quarter and fiscal year ended December 31, 2011.
>> read moreComplete Genomics Schedules Fourth Quarter and Fiscal Year 2011 Earnings Release and Announces Conference Call
Complete Genomics, Inc. (Nasdaq:GNOM) will release its fourth quarter and fiscal year 2011 financial results after markets close on March 8, 2012.
>> read moreComplete Genomics to Present at Two Upcoming Investor Conferences
Complete Genomics (NASDAQ: GNOM) today announced that members of its management team will present at the following conferences in March
>> read moreComplete Genomics Announces Formation of Genomic Medicine Advisory Board
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, today announced the formation of its Genomic Medicine Advisory Board (GMAB).
>> read moreStudy Published in Journal Nature Suggests New Genomic Pathways for Neuroblastoma
Complete Genomics, Inc. (NASDAQ: GNOM) announced today that the journal Nature has published a neuroblastoma study conducted using the company’s high-depth whole human genome sequencing service.
>> read moreInternational Standards for Cytogenomic Arrays (ISCA) Consortium Conference
Hyatt Regency, Bethesda, Maryland
>> read moreComplete Genomics 2012 Seminar Series - Finland: Genomic Information for Research & Beyond
Biomedicum, Helsinki and BioCity, Turku
>> read moreEuropean Human Genetics Conference (ESHG) 2012
Nürnberg Convention Center Ost, Nürnberg, Germany
>> read more